SQUAWK/NEWS
Menu
Live News EQUITY M impact

Tonix Pharma 8K Filing

Tonix Pharmaceuticals files 8K with SEC, disclosing other events and financial statements. Regulatory disclosure.

TNXP

Filed: 2026-05-27 AccNo: 0001493152-26-025324 Size: 22 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits